Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc.

APGE
Apogee Therapeutics, Inc.US flagNASDAQ Global Market
84.19
USD
+5.48
- -
5.21BMarket Cap

Income Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
31
93
217
286
+ Selling, General & Admin
3
25
49
70
+ Research & Development
28
68
168
215
+ Other Operating Expense
- -
- -
- -
1
Operating Income (Loss)
-31
-93
-217
-286
- Non-Operating (Income) Loss
9
-9
-35
-30
+ Interest Expense, Net
9
-9
-35
-30
+ Interest Expense
9
- -
- -
- -
- Interest Income
- -
9
35
30
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
Pretax Income
-40
-84
-182
-256
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-40
-84
-182
-256
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-40
-84
-182
-256
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-40
-84
-182
-256
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-40
-84
-182
-256
EBIT
-31
-93
-217
-286
EBITDA
-31
-93
-217
-284
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-31
-93
-217
-286
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
Basic Weighted Avg Shares
27
25
55
- -
Basic EPS, GAAP
-1.46
-3.36
-3.3
- -
Basic EPS from Cont Ops
-1.46
-3.36
-3.3
- -
Diluted Weighted Avg Shares
27
25
55
- -
Diluted EPS, GAAP
-1.46
-3.36
-3.3
- -
Diluted EPS from Cont Ops
-1.46
-3.36
-3.3
- -

Balance Sheet (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
152
398
530
741
+ Cash, Cash Equivalents & STI
152
395
521
730
+ Cash & Cash Equivalents
152
118
142
132
+ ST Investments
- -
277
379
599
+ Accounts & Notes Receiv
- -
1
5
6
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
1
5
6
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
2
4
5
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
- -
3
224
196
+ Property, Plant & Equip, Net
- -
3
13
14
+ Property, Plant & Equip
- -
3
14
16
- Accumulated Depreciation
- -
- -
- -
2
+ LT Investments & Receivables
- -
- -
210
173
+ LT Investments
- -
- -
210
173
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
9
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
9
Total Assets
152
401
754
937
+ Payables & Accruals
9
19
23
21
+ Accounts Payable
- -
2
1
1
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
9
17
22
20
+ ST Debt
- -
1
3
4
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
1
3
4
+ Other ST Liabilities
1
- -
2
4
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
1
- -
2
4
Total Current Liabilities
10
21
29
28
+ LT Debt
- -
1
9
5
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
- -
1
9
5
+ Other LT Liabilities
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
1
9
5
Total Liabilities
10
21
37
33
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
- -
503
1,022
1,465
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
- -
503
1,022
1,465
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-40
-124
-306
-562
+ Other Equity
- -
- -
1
1
Equity Before Minority Interest
142
380
717
904
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
142
380
717
904
Total Liabilities & Equity
152
401
754
937
Shares Outstanding
48
49
59
68
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
2
12
9
Net Debt
-152
-118
-142
-132
Net Debt to Equity
-106.91
-31.14
-19.78
-14.55
Tangible Common Equity Ratio
93.44
94.65
95.07
96.45
Current Ratio
15.24
19.38
18.55
26.57
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-40
-84
-182
-256
+ Depreciation & Amortization
- -
- -
- -
1
+ Non-Cash Items
14
3
13
42
+ Stock-Based Compensation
2
6
23
46
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
11
-3
-11
-4
+ Chg in Non-Cash Work Cap
10
6
-2
-15
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-3
-6
-2
+ Inc (Dec) in Accts Payable
10
9
5
-1
+ Inc (Dec) in Other
- -
- -
-1
-12
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-16
-75
-171
-227
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
-5
+ Acq of Fixed Prod Assets
- -
- -
-1
-5
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
315
493
390
+ Increase in Capital Stock
- -
315
493
390
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-274
-299
-174
+ Dec in LT Investment
- -
30
350
468
+ Inc in LT Investment
- -
-304
-649
-642
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
-274
-300
-180
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
168
- -
2
7
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
168
315
495
396
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
152
-33
23
-11
EBITDA
-31
-93
-217
-284
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-16
-75
-172
-233
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-75
-172
-233
Free Cash Flow per Basic Share
-0.6
-3
-3.12
- -
Price/Free Cash Flow
- -
-9.37
-14.71
- -
Cash Flow to Net Income
0.41
0.89
0.94
0.89
Capital Expenditures
- -
- -
-1
-5